Genomics in environmental health research - Opportunities and challenges

Toxicology

Volumn 198, Issue 1-3, 2004, Pages 19-24

  Olden, Kenneth ^a  

^a NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES   (United States)

Author keywords

'Omics'; Gene environment interactions; Polymorphism; Susceptibility; Systems biology; Toxicogenomics

Indexed keywords

ARTICLE; DATA BASE; GENE INTERACTION; GENETIC SUSCEPTIBILITY; GENOMICS; GENOTOXICITY; HUMAN; MEDICAL PRACTICE; MEDICAL RESEARCH; MODEL; MOLECULE; NONHUMAN; PREDICTION; PRIORITY JOURNAL; PROTEOMICS; RESEARCH; SINGLE NUCLEOTIDE POLYMORPHISM; TECHNOLOGY; TOXICITY; VALIDATION PROCESS;

ANIMALS; ENVIRONMENTAL HEALTH; GENETIC PREDISPOSITION TO DISEASE; GENOMICS; HUMANS; RESEARCH; TOXICOLOGY;

EID: 2342559207     PISSN: 0300483X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.tox.2004.01.015     Document Type: Article

References (20)

1. Afshari C.A. Perspective: microarray technology, seeing more than spots. Endocrinology. 14:2002;1983-1989
2. Brown P.O., Hartwell L. Genomics and human diseases - variations on variation. Nat. Genet. 18:1998;91-93
3. Burchiel S.W., Knoll C.M., Davis J.W., et al. Analysis of genetic and epigenetic mechanisms of toxicity: potential roles of toxicogenomics and proteomics in toxicology. Toxicol. Sci. 59:2001;193-195
4. Bushel P.R., Hamadeh H., Bennett L., Sieber S. MAPS: a microarray project system for gene expression experiment information and data variation. Bioinformatics. 17:2001;564-565
5. Costa L.G., Cole T.B., Jarvik G.P., Furlong C.E. Functional genomics of the paraoxonase (PON1) polymorphisms: effects on pesticide sensitivity, cardiovascular disease, and drug metabolism. Annu. Rev. Med. 54:2003;371-392
6. Guengerich F.P. The environmental genome project: functional analysis of polymorphisms. Environ. Health Perspect. 106:1998;365-368
7. Ingelman M.S., Oscarson M., McLellan R. Polymorphic human cytochrome P450 enzymes: an opportunity for individualized drug treatment. Trends Pharmacol. Sci. 20:1999;342-348
8. Kaiser J. Environment institute lays plans for gene hunt. Science. 278:1997;569-570
9. Khat U.M., Khat M.B., Bayzer C.T., et al. Prevalence of conventional risk factors in patients with coronary heart disease. J. Am. Med. Assoc. 290:2003;899-904
10. Lichtenstein P., Niels V.H., Verkasala P.K., Iliadou A., Kapria J., et al. Environmental and heritable factors in the causation of cancer. Analysis of cohorts of twins from Sweden, Denmark, and Finland. New Eng. J. Med. 343:2000;78-85
11. Nebert D.W., McKinnon R.A., Puga A. Human drug-metabolizing enzyme polymorphisms: effects on risk of toxicity and cancer. DNA Cell Biol. 15:1996;273-280
12. Nebert D.W., McKinnon R.A. Cytochrome P450: evolution of functional diversity. Prog. Liver Dis. 12:1994;63-97
13. Neuvaysir E.F., Bittner M., Trent J., et al. Microarrays and toxicology: the advent of toxicogenomics. Mol. Carcinog. 24:1999;153-159
14. Olden K., Wilson S.H. Environmental health and genomics: visions and implications. Nat. Rev. Genet. 1:2000;149-153
15. Olden, K., 2004. Use of 'Omic" approaches in unraveling mechanisms of gene environment interactions, Current Genomics 5, 1-6.
16. Olden K. New opportunities in toxicology in the post-genome era. Drug Discovery Today. 7:2002;273-276
17. Powell J.J., Vande Water J., Gerschwin M.E. Evidence for the role of environmental agents in the initiation or progression of autoimmune conditions. Environ. Health Pespect. 107(Suppl. 5):1999;667-672
18. Tanner C.M., Ottman R., Goldman S.M., et al. Parkinson's disease in twins: an etiologic study. J. Am. Med. Assoc. 281:1999;341-346
19. Verkasala P.K., Kapria J., Kaskenvua M., Pukkala E. Genetic predisposition, environment and cancer incidence: a national twin study in Finland. Int. J. Cancer. 83:1999;743-749
20. Waters M., Boorman G., Bushel P., Cunningham M., et al. Systems toxicology and the chemical effects on biological systems (CEBS) knowledge base. Environ. Health Perspect. Toxicogenom. 111:2003;15-28